WB4101-related compounds: New, subtype-selective α1- adrenoreceptor antagonists (or inverse agonists?)

Marco Pallavicini, Roberta Budriesi, Laura Fumagalli, Pierfranco Ioan, Alberto Chiarini, Cristiano Bolchi, Maria Paola Ugenti, Simona Colleoni, Marco Gobbi, Ermanno Valoti

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Our previous structure-affinity relationship study had considered the enantiomers of the naphthodioxane, tetrahydronaphthodioxane, and 2-methoxy-1-naphthoxy analogues (compounds 1, 3, and 2, respectively) of 2-(2,6-dimethoxyphenoxyethylaminomethyl)-1,4-benzodioxane, the well-known α1-adrenoceptor (α1-AR) antagonist WB4101, showing that such modifications significantly modulate the affinity and selectivity profile for α1-AR subtypes and 5-HT1A receptor. Here, we extend investigations to antagonist activity enclosing new enantiomeric pairs, namely those of the methoxytetrahydronaphthoxy and methoxybiphenyloxy WB4101 analogues (4 and 5-7, respectively) and of a double-modified WB4101 derivative (8) resulting from hybridization between 2 and 3. We found that (S)-2 is a very potent (pA2 10.68) and moderately selective α1D-AR antagonist and the hybrid (S)-8 is a potent (pA2 7.98) and highly selective α1A-AR antagonist. Both of these compounds and (S)-WB4101 seem to act as inverse agonists in a vascular model. The results, which generally validate the logic we followed in designing these eight compounds, are acceptably rationalized by comparative SAR analysis of binding and functional affinities.

Original languageEnglish
Pages (from-to)7140-7149
Number of pages10
JournalJournal of Medicinal Chemistry
Volume49
Issue number24
DOIs
Publication statusPublished - Nov 30 2006

Fingerprint

Adrenergic Receptors
Receptor, Serotonin, 5-HT1A
Enantiomers
Blood Vessels
Derivatives
(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane
S(8)

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Pallavicini, M., Budriesi, R., Fumagalli, L., Ioan, P., Chiarini, A., Bolchi, C., ... Valoti, E. (2006). WB4101-related compounds: New, subtype-selective α1- adrenoreceptor antagonists (or inverse agonists?). Journal of Medicinal Chemistry, 49(24), 7140-7149. https://doi.org/10.1021/jm060358r

WB4101-related compounds : New, subtype-selective α1- adrenoreceptor antagonists (or inverse agonists?). / Pallavicini, Marco; Budriesi, Roberta; Fumagalli, Laura; Ioan, Pierfranco; Chiarini, Alberto; Bolchi, Cristiano; Ugenti, Maria Paola; Colleoni, Simona; Gobbi, Marco; Valoti, Ermanno.

In: Journal of Medicinal Chemistry, Vol. 49, No. 24, 30.11.2006, p. 7140-7149.

Research output: Contribution to journalArticle

Pallavicini, M, Budriesi, R, Fumagalli, L, Ioan, P, Chiarini, A, Bolchi, C, Ugenti, MP, Colleoni, S, Gobbi, M & Valoti, E 2006, 'WB4101-related compounds: New, subtype-selective α1- adrenoreceptor antagonists (or inverse agonists?)', Journal of Medicinal Chemistry, vol. 49, no. 24, pp. 7140-7149. https://doi.org/10.1021/jm060358r
Pallavicini, Marco ; Budriesi, Roberta ; Fumagalli, Laura ; Ioan, Pierfranco ; Chiarini, Alberto ; Bolchi, Cristiano ; Ugenti, Maria Paola ; Colleoni, Simona ; Gobbi, Marco ; Valoti, Ermanno. / WB4101-related compounds : New, subtype-selective α1- adrenoreceptor antagonists (or inverse agonists?). In: Journal of Medicinal Chemistry. 2006 ; Vol. 49, No. 24. pp. 7140-7149.
@article{0037ab4404d34216ae6a6fc96519f038,
title = "WB4101-related compounds: New, subtype-selective α1- adrenoreceptor antagonists (or inverse agonists?)",
abstract = "Our previous structure-affinity relationship study had considered the enantiomers of the naphthodioxane, tetrahydronaphthodioxane, and 2-methoxy-1-naphthoxy analogues (compounds 1, 3, and 2, respectively) of 2-(2,6-dimethoxyphenoxyethylaminomethyl)-1,4-benzodioxane, the well-known α1-adrenoceptor (α1-AR) antagonist WB4101, showing that such modifications significantly modulate the affinity and selectivity profile for α1-AR subtypes and 5-HT1A receptor. Here, we extend investigations to antagonist activity enclosing new enantiomeric pairs, namely those of the methoxytetrahydronaphthoxy and methoxybiphenyloxy WB4101 analogues (4 and 5-7, respectively) and of a double-modified WB4101 derivative (8) resulting from hybridization between 2 and 3. We found that (S)-2 is a very potent (pA2 10.68) and moderately selective α1D-AR antagonist and the hybrid (S)-8 is a potent (pA2 7.98) and highly selective α1A-AR antagonist. Both of these compounds and (S)-WB4101 seem to act as inverse agonists in a vascular model. The results, which generally validate the logic we followed in designing these eight compounds, are acceptably rationalized by comparative SAR analysis of binding and functional affinities.",
author = "Marco Pallavicini and Roberta Budriesi and Laura Fumagalli and Pierfranco Ioan and Alberto Chiarini and Cristiano Bolchi and Ugenti, {Maria Paola} and Simona Colleoni and Marco Gobbi and Ermanno Valoti",
year = "2006",
month = "11",
day = "30",
doi = "10.1021/jm060358r",
language = "English",
volume = "49",
pages = "7140--7149",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "24",

}

TY - JOUR

T1 - WB4101-related compounds

T2 - New, subtype-selective α1- adrenoreceptor antagonists (or inverse agonists?)

AU - Pallavicini, Marco

AU - Budriesi, Roberta

AU - Fumagalli, Laura

AU - Ioan, Pierfranco

AU - Chiarini, Alberto

AU - Bolchi, Cristiano

AU - Ugenti, Maria Paola

AU - Colleoni, Simona

AU - Gobbi, Marco

AU - Valoti, Ermanno

PY - 2006/11/30

Y1 - 2006/11/30

N2 - Our previous structure-affinity relationship study had considered the enantiomers of the naphthodioxane, tetrahydronaphthodioxane, and 2-methoxy-1-naphthoxy analogues (compounds 1, 3, and 2, respectively) of 2-(2,6-dimethoxyphenoxyethylaminomethyl)-1,4-benzodioxane, the well-known α1-adrenoceptor (α1-AR) antagonist WB4101, showing that such modifications significantly modulate the affinity and selectivity profile for α1-AR subtypes and 5-HT1A receptor. Here, we extend investigations to antagonist activity enclosing new enantiomeric pairs, namely those of the methoxytetrahydronaphthoxy and methoxybiphenyloxy WB4101 analogues (4 and 5-7, respectively) and of a double-modified WB4101 derivative (8) resulting from hybridization between 2 and 3. We found that (S)-2 is a very potent (pA2 10.68) and moderately selective α1D-AR antagonist and the hybrid (S)-8 is a potent (pA2 7.98) and highly selective α1A-AR antagonist. Both of these compounds and (S)-WB4101 seem to act as inverse agonists in a vascular model. The results, which generally validate the logic we followed in designing these eight compounds, are acceptably rationalized by comparative SAR analysis of binding and functional affinities.

AB - Our previous structure-affinity relationship study had considered the enantiomers of the naphthodioxane, tetrahydronaphthodioxane, and 2-methoxy-1-naphthoxy analogues (compounds 1, 3, and 2, respectively) of 2-(2,6-dimethoxyphenoxyethylaminomethyl)-1,4-benzodioxane, the well-known α1-adrenoceptor (α1-AR) antagonist WB4101, showing that such modifications significantly modulate the affinity and selectivity profile for α1-AR subtypes and 5-HT1A receptor. Here, we extend investigations to antagonist activity enclosing new enantiomeric pairs, namely those of the methoxytetrahydronaphthoxy and methoxybiphenyloxy WB4101 analogues (4 and 5-7, respectively) and of a double-modified WB4101 derivative (8) resulting from hybridization between 2 and 3. We found that (S)-2 is a very potent (pA2 10.68) and moderately selective α1D-AR antagonist and the hybrid (S)-8 is a potent (pA2 7.98) and highly selective α1A-AR antagonist. Both of these compounds and (S)-WB4101 seem to act as inverse agonists in a vascular model. The results, which generally validate the logic we followed in designing these eight compounds, are acceptably rationalized by comparative SAR analysis of binding and functional affinities.

UR - http://www.scopus.com/inward/record.url?scp=33845349565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845349565&partnerID=8YFLogxK

U2 - 10.1021/jm060358r

DO - 10.1021/jm060358r

M3 - Article

C2 - 17125266

AN - SCOPUS:33845349565

VL - 49

SP - 7140

EP - 7149

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 24

ER -